Actively Recruiting
A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)
Led by Seven Oaks Hospital Chronic Disease Innovation Centre · Updated on 2026-04-22
54
Participants Needed
2
Research Sites
61 weeks
Total Duration
On this page
Sponsors
S
Seven Oaks Hospital Chronic Disease Innovation Centre
Lead Sponsor
U
University of Manitoba
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare protein supplements in patients with kidney failure on dialysis. The main questions it aims to answer are: * To determine whether the supplementation of egg white protein pudding in a population of individuals with kidney failure on dialysis is feasible. * To determine whether egg white protein pudding supplementation improves serum albumin similar to other standard nutritional supplements. * To determine the effects of the egg white protein pudding on frailty measures, dietary intakes and analytes in the blood. Participants will receive either the egg white pudding (experimental) or control (Ensure plus) at the end of their dialysis treatments 3-days per week for 12 weeks.
CONDITIONS
Official Title
A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is willing and able to give informed consent for participation in the trial
- Male or female aged 6518 years with chronic kidney disease
- On chronic in-center hemodialysis for more than 3 months
- Serum albumin less than 35 g/L
- No expected change in dialysis method or moving outside Winnipeg during the 12-week intervention period
You will not qualify if you...
- Allergy to eggs
- History of renal transplant
- Serum albumin 35 g/L or higher
- Bowel diseases
- Cancer
- Pregnancy
- Receiving chemotherapy treatment
- Unable to consume the study treatment product
- Allergy to any study treatment ingredients
- Planning to start an exercise program during the trial
- Unable to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Seven Oaks General Hospital
Winnipeg, Manitoba, Canada, R2V 3M3
Actively Recruiting
2
Health Science Centre
Winnipeg, Manitoba, Canada, R3A 1R9
Actively Recruiting
Research Team
N
Navdeep Tangri, MD, PhD
CONTACT
T
Tahmina Rahman, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here